Surge Laboratories: Your Partner in Manufacturing Excellence

At Surge, our unwavering commitment to manufacturing excellence has been at the heart of our journey since day one. We take pride in our cutting-edge cGMP-compliant manufacturing facility, strategically situated in Sheikhupura, near Lahore, Pakistan. Over the years, we have made substantial investments in technology to mitigate risks and ensure the production of premium-quality pharmaceutical products.

Our facility is fully equipped with the latest machinery and equipment, boasting dedicated cGMP-compliant manufacturing sections for Liquid Injectables, Dry Powder Injectables, and Microencapsulated APIs and Excipients.

Diversified Dosage Forms of Branded Generic formulations

Over the past two decades, Surge Laboratories has emerged as a leading manufacturer in the industry. We specialize in Large Volume Parenteral, Small Volume Parenteral, Respules, and Dry Powder Vials, including renowned products like Artesunate Injection and a variety of general pharmaceutical offerings.

In addition, we maintain a separate, self-contained facility for Sterile Dry Powder Cephalosporin Injectables, designed for our branded generic formulations

Cutting-Edge Microencapsulation Technology

We’ve taken strides in adopting advanced microencapsulation technology, incorporating lab, pilot, commercial, and bulk scale cGMP compliant equipment from Germany. This technology empowers us to perform a series of coating operations, including taste masking of bitter substances and EC/MR/DDR/SR coating of APIs in pellets and granules for various pharmaceutical forms, such as capsules, tablets, sachets, and orally dispersible tablets.

Microencapsulation is the process by which small particles or droplets are surrounded by a coating to produce capsules for the purpose of shielding the API or excipient from the surrounding environment in the micrometer to millimeter range.